Background: Cancer patients of the Department of Internal Medicine (Cancer Research) of
the Essen University Medical School (Tumor Clinics), Germany, were examined and …

Background: The incidence of venous thrombosis (VT) for cancer patients is increased
compared with patients without cancer, but estimations of the incidence for different types of …

Background. Venous thromboembolism (VTE) is a common complication in cancer patients
and a significant cause of morbidity and mortality. However, little information is available on …

Deep venous thrombosis (DVT) and pulmonary embolism (PE) are well recognized
complications of cancer. However, our current knowledge of this association is derived from …

Although cancer is recognized as a major risk factor for venous thromboembolism, the exact
magnitude of the problem and specific risk factors most strongly associated with the …

Cancer is associated with a fourfold increased risk of venous thromboembolism (VTE). The
risk of VTE varies according to the type of malignancy (ie pancreatic cancer, brain cancer …

Background People with cancer are known to be at increased risk of venous
thromboembolism (VTE), and this risk is believed to vary according to cancer type, stage of …

Background: Only limited data on the incidence of venous thrombosis in different types of
malignancy are available. Patients with adenocarcinoma are believed to have the highest …

The risk of venous thromboembolism (VTE) is increased in cancer patients. To improve
prediction of VTE in cancer patients, we performed a prospective and observational cohort …

Background. Retrospective studies have suggested an association between cancer-
associated venous thromboembolism (VTE) and patient survival. We evaluated a previously …